The molecular basis of HCV-mediated immune dysregulation

Chronic hepatitis C virus (HCV) infection, which occurs in over 85% of patients and causes mild to severe liver disease, is a growing burden to health systems worldwide. The propensity of HCV to establish persistent infection suggests that the virus, which is non-cytopathic, has evolved one or more...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 111(2004), 1 vom: 01. Apr., Seite 16-21
1. Verfasser: Eisen-Vandervelde, Audrey L (VerfasserIn)
Weitere Verfasser: Yao, Zhi Qiang, Hahn, Young S
Format: Aufsatz
Sprache:English
Veröffentlicht: 2004
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, U.S. Gov't, P.H.S. Review Viral Core Proteins
LEADER 01000naa a22002652 4500
001 NLM147873290
003 DE-627
005 20231223044322.0
007 tu
008 231223s2004 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0493.xml 
035 |a (DE-627)NLM147873290 
035 |a (NLM)15093547 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Eisen-Vandervelde, Audrey L  |e verfasserin  |4 aut 
245 1 4 |a The molecular basis of HCV-mediated immune dysregulation 
264 1 |c 2004 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 27.05.2004 
500 |a Date Revised 14.11.2007 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Chronic hepatitis C virus (HCV) infection, which occurs in over 85% of patients and causes mild to severe liver disease, is a growing burden to health systems worldwide. The propensity of HCV to establish persistent infection suggests that the virus, which is non-cytopathic, has evolved one or more mechanisms aimed at evading host immunity. In addition to the appearance of quasispecies, which may arise under selective pressure during B and T cell responses, HCV gene products interact with host proteins in order to subvert immune surveillance. Gaining insight into these interactions may provide the basis for novel therapies aimed at preventing chronic HCV infection 
650 4 |a Journal Article 
650 4 |a Research Support, U.S. Gov't, P.H.S. 
650 4 |a Review 
650 7 |a Viral Core Proteins  |2 NLM 
700 1 |a Yao, Zhi Qiang  |e verfasserin  |4 aut 
700 1 |a Hahn, Young S  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 111(2004), 1 vom: 01. Apr., Seite 16-21  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:111  |g year:2004  |g number:1  |g day:01  |g month:04  |g pages:16-21 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 111  |j 2004  |e 1  |b 01  |c 04  |h 16-21